Promega Corporation

Technically Speaking: Anti-ACTIVE™ Antibodies to MAPK JNK and p38

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

Promega has combined state-of-the-art phosphopeptide synthesis, antibody production and purification strategies to generate three highly selective antibodies raised against the active form of key enzymes of the ERK/MAP kinase superfamily. These rabbit polyclonal Anti-ACTIVE™ Antibodies are specific to the active, dually phosphorylated forms of these enzymes and can be used to detect active enzyme by a variety of methods.

Promega Notes 64, 31.

Doug Barron

Promega Corporation
Publication Date: 1997

Download Article (162 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.